SCHEMBL5340807

SCHEMBL5340807

FC(F)(F)c1cccc(-c2cnc3nc(-c4ccc(Cl)cc4)cn3c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 5/20 0.52
KCNH2 Q12809 2/20 0.52
ALDH1A1 P00352 5/20 0.48
RAB9A P51151 5/20 0.48
KDM4E B2RXH2 4/20 0.48
HPGD P15428 3/20 0.48
GAA P10253 2/20 0.48
GLA P06280 1/20 0.48
NPC1 O15118 4/20 0.44
NFKB1 P19838 3/20 0.44
NFKB2 Q00653 3/20 0.44
RELA Q04206 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 2/20 0.44
APP P05067 1/20 0.44
GRM5 P41594 2/20 0.43
CYP2C9 P11712 2/20 0.43
VCP P55072 1/20 0.42
ALDH1A3 P47895 1/20 0.42
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5341562 0.89 NR3C1 (0.49) ALDH1A1RAB9AKDM4ENPC1NFKB1
SCHEMBL5350108 0.80 GRM5 (0.47) ALDH1A1KDM4EGRM5MAOB
SCHEMBL5338540 0.77 AKT1 (0.46) ALDH1A1RAB9AKDM4EGAAGLA
SCHEMBL5340690 0.76 MAOB (0.40) ALDH1A1RAB9AKDM4EGAAGLA
Hydrochloric Acid SCHEMBL5344599 0.76 AKT1 (0.45) ALDH1A1RAB9AKDM4EGAAGLA
SCHEMBL5346776 0.73 AKT1 (0.42) RAB9AKDM4EGAANPC1SMN1; SMN2
SCHEMBL11470852 0.73 MAOB (0.46) ALDH1A1RAB9AKDM4EGAANPC1
SCHEMBL5343644 0.71 GRIN1 (0.46) ALDH1A1RAB9AKDM4EHPGDGAA
SCHEMBL5319387 0.71 AKT1 (0.41) ALDH1A1RAB9AGAANPC1SMN1; SMN2
SCHEMBL11158643 0.70 CCNA2 (0.55) ALDH1A1GAAMAOBCCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO disclosed